118 related articles for article (PubMed ID: 35131083)
21. The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line.
Jackson DP; Watling D; Rogers NC; Banks RE; Kerr IM; Selby PJ; Patel PM
Melanoma Res; 2003 Jun; 13(3):219-29. PubMed ID: 12777975
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.
Böhm M; Schulte U; Funk JO; Raghunath M; Behrmann I; Kortylewski M; Heinrich PC; Kues T; Luger TA; Schwarz T
J Invest Dermatol; 2001 Jul; 117(1):132-40. PubMed ID: 11442760
[TBL] [Abstract][Full Text] [Related]
23. LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.
Liu W; Monahan KB; Pfefferle AD; Shimamura T; Sorrentino J; Chan KT; Roadcap DW; Ollila DW; Thomas NE; Castrillon DH; Miller CR; Perou CM; Wong KK; Bear JE; Sharpless NE
Cancer Cell; 2012 Jun; 21(6):751-64. PubMed ID: 22698401
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of STAT3 signalling contributes to the antimelanoma action of atractylenolide II.
Fu XQ; Chou GX; Kwan HY; Tse AK; Zhao LH; Yuen TK; Cao HH; Yu H; Chao XJ; Su T; Cheng BC; Sun XG; Yu ZL
Exp Dermatol; 2014 Nov; 23(11):855-7. PubMed ID: 25073716
[TBL] [Abstract][Full Text] [Related]
25. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
26. c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.
Ganguly SS; Fiore LS; Sims JT; Friend JW; Srinivasan D; Thacker MA; Cibull ML; Wang C; Novak M; Kaetzel DM; Plattner R
Oncogene; 2012 Apr; 31(14):1804-16. PubMed ID: 21892207
[TBL] [Abstract][Full Text] [Related]
27. Expression of phosphorylated-STAT3 and osteopontin and their correlation in melanoma.
Wu Y; Jiang P; Lin Y; Chen S; Lin N; Li J
J Huazhong Univ Sci Technolog Med Sci; 2009 Apr; 29(2):246-50. PubMed ID: 19399415
[TBL] [Abstract][Full Text] [Related]
28. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
[TBL] [Abstract][Full Text] [Related]
29. Identification of key candidate genes involved in melanoma metastasis.
Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
[TBL] [Abstract][Full Text] [Related]
30. The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.
Humbert L; Ghozlan M; Canaff L; Tian J; Lebrun JJ
BMC Cancer; 2015 Mar; 15():200. PubMed ID: 25885043
[TBL] [Abstract][Full Text] [Related]
31. Targeting leucine addiction and autophagy in melanoma.
Diaz-Meco MT
Pigment Cell Melanoma Res; 2011 Aug; 24(4):588-9. PubMed ID: 22489330
[No Abstract] [Full Text] [Related]
32. DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling.
Steder M; Alla V; Meier C; Spitschak A; Pahnke J; Fürst K; Kowtharapu BS; Engelmann D; Petigk J; Egberts F; Schäd-Trcka SG; Gross G; Nettelbeck DM; Niemetz A; Pützer BM
Cancer Cell; 2013 Oct; 24(4):512-27. PubMed ID: 24135282
[TBL] [Abstract][Full Text] [Related]
33. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML
Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358
[TBL] [Abstract][Full Text] [Related]
34. Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway.
Kardos GR; Wastyk HC; Robertson GP
Mol Cancer Res; 2015 Oct; 13(10):1408-20. PubMed ID: 26082174
[TBL] [Abstract][Full Text] [Related]
35. Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles.
Pan J; Ruan W; Qin M; Long Y; Wan T; Yu K; Zhai Y; Wu C; Xu Y
Sci Rep; 2018 Jan; 8(1):1117. PubMed ID: 29348670
[TBL] [Abstract][Full Text] [Related]
36. Divergence(s) in nodal signaling between aggressive melanoma and embryonic stem cells.
Khalkhali-Ellis Z; Kirschmann DA; Seftor EA; Gilgur A; Bodenstine TM; Hinck AP; Hendrix MJ
Int J Cancer; 2015 Mar; 136(5):E242-51. PubMed ID: 25204799
[TBL] [Abstract][Full Text] [Related]
37. Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells.
Bonet C; Giuliano S; Ohanna M; Bille K; Allegra M; Lacour JP; Bahadoran P; Rocchi S; Ballotti R; Bertolotto C
J Biol Chem; 2012 Aug; 287(35):29887-98. PubMed ID: 22767597
[TBL] [Abstract][Full Text] [Related]
38. The JAK2/STAT3 pathway is involved in the anti-melanoma effects of atractylenolide I.
Fu XQ; Chou JY; Li T; Zhu PL; Li JK; Yin CL; Su T; Guo H; Lee KW; Hossen MJ; Chou GX; Yu ZL
Exp Dermatol; 2018 Feb; 27(2):201-204. PubMed ID: 29078004
[TBL] [Abstract][Full Text] [Related]
39. Signal transducer and activator of transcription 3 upregulates interleukin-8 expression at the level of transcription in human melanoma cells.
Oka M; Sakaguchi M; Okada T; Nagai H; Ozaki M; Yoshioka T; Inoue H; Mukaida N; Kikkawa U; Nishigori C
Exp Dermatol; 2010 Aug; 19(8):e50-5. PubMed ID: 19758315
[TBL] [Abstract][Full Text] [Related]
40. Emerging molecular targets in melanoma invasion and metastasis.
Orgaz JL; Sanz-Moreno V
Pigment Cell Melanoma Res; 2013 Jan; 26(1):39-57. PubMed ID: 23095214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
